Skip to main content
SpringerLink
Log in

Rivaroxaban cost effective for prevention of VTE

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Brockbank J, et al. Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review. PharmacoEconomics : 10 Feb 2017. Available from: URL: http://doi.org/10.1007/s40273-017-0486-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rivaroxaban cost effective for prevention of VTE. PharmacoEcon Outcomes News 772, 32 (2017). https://doi.org/10.1007/s40274-017-3780-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3780-7

Search

Navigation